Chronic Migraine research hub

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine

This study is testing a new injection, Xeomin, for people with frequent migraines. We want to see if it reduces the number of migraine days compared to a dummy injection (placebo). It involves head and neck injections and lasts about a year.

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

This study is testing a medicine called Dysport® for people who get chronic migraines. It aims to see if Dysport® can reduce how often and how bad migraines are, and if it's safe to use, compared to a dummy medicine.

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

This study looks into a new medicine called IPN10200, given as injections, to see if it can prevent migraine headaches in adults. It will check if the treatment is safe and how well it works for people who get migraines often.

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

This study is testing a new tablet called atogepant to see if it can help prevent chronic migraines in young people aged 12 to 17. We want to know if it's safe and if it works better than a dummy pill.

Interventional, randomized, double-blind, parallel-group, placebo-controlled study to evaluate efficacy and safety of eptinezumab for the preventive treatment of migraine

MiBlock - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic migraine

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM])